Bavarian Nordic’s Mpox vaccine met with the World Health ... decision comes after the European Union (EU) approved the drug ...

The first mpox vaccine approved by the WHO is MVA-BN, made by Bavarian Nordic A/S. It was approved for emergency use and can be used "off-label" in infants, children and adolescents as well as in ...

Interim results from the NIH study enrolled 229 adolescents ... Nordic's vaccine – also known as Imvanex and Imvamune – has been approved in the US, Europe, and Canada for the prevention of ...

During the 2022–2023 mpox outbreak ... both pre- and post-exposure use in adolescents. The NIH stated that whilst several countries have approved the vaccine for the prevention of mpox and ...

Adults started getting vaccinations against mpox in Democratic Republic of Congo's capital this week. But there were no shots ...

In a statement late Tuesday, the U.N. health agency said it had approved the mpox vaccine made by Japanese company KM Biologics for use in children over 1 year of age as a single dose. Earlier this ...

Only LC16 has been approved in children, who have been badly hit by the current outbreak. Vials of mpox vaccine. All three of the main vaccines for the virus originated as shots against smallpox ...

Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for ...